Roche wins further marketing approval for Tamiflu

The drugs giant, Roche, said on Monday that it had received approval from the United States Food and Drug Administration to market Tamiflu as a preventative medicine against influenza.

This content was published on November 20, 2000 - 15:27

The decision means that Tamiflu will be available this winter as a preventative drug.

It was approved by the FDA in October 1999 as a treatment for those already showing symptoms.

Around 40 million Americans develop the flu every year.

Roche developed Tamiflu in collaboration with Gilead Sciences. It helps prevent all common strains of the flu virus.

The use of the drug in preventative treatment is still awaiting approval in a number of markets including Canada.

swissinfo with agencies

This article was automatically imported from our old content management system. If you see any display errors, please let us know:

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI certified by the Journalism Trust Initiative

Contributions under this article have been turned off. You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at

Share this story

Change your password

Do you really want to delete your profile?